Compare VCEL & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | FOXX |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 17.3M |
| IPO Year | 1996 | 2025 |
| Metric | VCEL | FOXX |
|---|---|---|
| Price | $40.37 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.75 | N/A |
| AVG Volume (30 Days) | ★ 433.6K | 5.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $276,259,000.00 | $52,584,432.00 |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $1.71 |
| 52 Week High | $49.32 | $7.90 |
| Indicator | VCEL | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 47.79 |
| Support Level | $33.21 | $2.29 |
| Resistance Level | $41.12 | $4.84 |
| Average True Range (ATR) | 1.26 | 0.18 |
| MACD | 0.25 | 0.01 |
| Stochastic Oscillator | 81.62 | 63.76 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.